SANOFI has been ordered to pay
€40.6m in penalties for a “smear
campaign” in France targeting
generic versions of Plavix.
The French competition authority
alleged that Sanofi’s sales force
criticised the generics when talking
with pharmacists and doctors in
2009 and 2010, as well as urging
medical practitioners not to allow
substitution on prescriptions.
Plavix was the most costly
medicine for France’s health system
in 2008, costing €625m.
Sanofi said it’s “reviewing all the
points to prepare an appeal”.The above article was sent to subscribers in Pharmacy Daily's issue from 16 May 13 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 May 13
PEAK pharmacy bodies are calling on the Australian Government to extend the new Commonwealth Prac Payment to pharmacy students, citing the challenges of “placement poverty” in unpaid practical placements.
AFT Pharmaceuticals is set to develop a topical treatment for keloid and hypertrophic scarring in partnership with NZ’s Massey Ventures, the commercialisation arm of Massey University, and the Gillies McIndoe Research Institute.
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.